Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

May 8, 2024

Study Completion Date

May 13, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

AGMB-129

Each participant will receive 3 study interventions, 1 in each intervention period

Trial Locations (1)

SGS Belgium, Edegem

All Listed Sponsors

lead

Agomab Spain S.L.

INDUSTRY

NCT06397508 - Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants | Biotech Hunter | Biotech Hunter